{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:05:02Z","timestamp":1761408302921,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,25]],"date-time":"2024-01-25T00:00:00Z","timestamp":1706140800000},"content-version":"vor","delay-in-days":24,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Brazilian Journal of Infectious Diseases"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.bjid.2024.103718","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T17:03:44Z","timestamp":1707239024000},"page":"103718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Six-year experience with GM test in hematological patients in a public Brazilian tertiary hospital"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7814-5387","authenticated-orcid":false,"given":"Lucieni Oliveira","family":"Conterno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0588-4859","authenticated-orcid":false,"given":"Pl\u00ednio","family":"Trabasso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6976-8884","authenticated-orcid":false,"given":"Mari\u00e2ngela Ribeiro","family":"Resende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2214-2769","authenticated-orcid":false,"given":"Paula Sanches","family":"Paschoali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2287-664X","authenticated-orcid":false,"given":"Leticia Bergamo","family":"Pascucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2280-5649","authenticated-orcid":false,"given":"Maria Luiza","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bjid.2024.103718_bib0001","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.idc.2021.03.008","article-title":"Aspergillosis: epidemiology, diagnosis, and treatment","volume":"35","author":"Cadena","year":"2021","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.bjid.2024.103718_bib0002","doi-asserted-by":"crossref","first-page":"e462","DOI":"10.3324\/haematol.2015.126698","article-title":"Epidemiology of invasive fungal disease in lymphoproliferative disorders","volume":"100","author":"Teng","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.bjid.2024.103718_bib0003","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1086\/651263","article-title":"Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001\u20132006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database","volume":"50","author":"Kontoyiannis","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"Suppl 7","key":"10.1016\/j.bjid.2024.103718_bib0004","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1111\/imj.15588","article-title":"Australasian Antifungal Guidelines Steering Committee. Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2021","volume":"51","author":"Teh","year":"2021","journal-title":"Intern Med J"},{"key":"10.1016\/j.bjid.2024.103718_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104382","article-title":"Enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation","volume":"147","author":"Ardi","year":"2020","journal-title":"Microb Pathog"},{"key":"10.1016\/j.bjid.2024.103718_bib0006","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.3747\/co.25.3848","article-title":"Adherence to, and outcomes of, a galactomannan screening protocol in high-risk hematology patients","volume":"25","author":"Harricharan","year":"2018","journal-title":"Curr Oncol"},{"key":"10.1016\/j.bjid.2024.103718_bib0007","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/jac\/dkp507","article-title":"Overall survival and fungal infection-related mortality in patients with invasive fungal infection and neutropenia after myelosuppressive chemotherapy in a tertiary care centre from 1995 to 2006","volume":"65","author":"Hahn-Ast","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2024.103718_bib0008","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1086\/496927","article-title":"Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study","volume":"41","author":"Maertens","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2024.103718_bib0009","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/cid\/ciz1008","article-title":"Revision and update of the consensus definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium","volume":"71","author":"Donnelly","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2024.103718_bib0010","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1473-3099(15)70006-X","article-title":"British Society for Medical Mycology. British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases","volume":"15","author":"Schelenz","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"2015","key":"10.1016\/j.bjid.2024.103718_bib0011","article-title":"Galactomannan detection for invasive aspergillosis in immunocompromised patients","volume":"30","author":"Leeflang","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bjid.2024.103718_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140930","article-title":"Meta-analysis and cost comparison of empirical versus pre-emptive antifungal strategies in hematologic malignancy patients with high-risk febrile neutropenia","volume":"10","author":"Fung","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bjid.2024.103718_bib0013","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.bjid.2016.04.007","article-title":"Diagnostic-driven antifungal therapy in neutropenic patients using the D-index and serial serum galactomannan testing","volume":"20","author":"Garnica","year":"2016","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.bjid.2024.103718_bib0014","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1186\/s12879-018-3584-9","article-title":"Treating invasive aspergillosis in patients with hematologic malignancy: diagnostic-driven approach versus empiric therapies","volume":"18","author":"Dib","year":"2018","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bjid.2024.103718_bib0015","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2024.103718_bib0016","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jmii.2017.05.007","article-title":"Clinical characteristics, radiologic findings, risk factors and outcomes of serum galactomannan-negative invasive pulmonary aspergillosis","volume":"51","author":"Jung","year":"2018","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.bjid.2024.103718_bib0017","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1186\/s12879-019-4039-7","article-title":"Utility of CT assessment in hematology patients with invasive aspergillosis: a post-hoc analysis of phase 3 data","volume":"19","author":"Jin","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bjid.2024.103718_bib0018","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1093\/cid\/ciaa1855","article-title":"Guidance on imaging for invasive pulmonary aspergillosis and mucormycosis: from the Imaging working Group for the Revision and Update of the Consensus Definitions of Fungal Disease from the EORTC\/MSGERC","volume":"72","author":"Alexander","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2024.103718_bib0019","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/myc.13205","article-title":"Epidemiology of invasive fungal disease in haematologic patients","volume":"64","author":"Souza","year":"2021","journal-title":"Mycoses"},{"key":"10.1016\/j.bjid.2024.103718_bib0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.ccm.2009.03.001","article-title":"Fungal infections in hematopoietic stem cell transplantation and solid-organ transplantation\u2013focus on aspergillosis","volume":"30","author":"Nucci","year":"2009","journal-title":"Clin Chest Med"},{"key":"10.1016\/j.bjid.2024.103718_bib0021","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/1469-0691.12002","article-title":"Invasive fungal diseases in haematopoietic cell transplant recipients and in patients with acute myeloid leukaemia or myelodysplasia in Brazil","volume":"19","author":"Nucci","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"Suppl 7","key":"10.1016\/j.bjid.2024.103718_bib0022","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/imj.15591","article-title":"Australasian Antifungal Guidelines Steering Committee. Consensus guidelines for the diagnosis and management of invasive aspergillosis","volume":"51","author":"Douglas","year":"2021","journal-title":"Intern Med J"},{"key":"10.1016\/j.bjid.2024.103718_bib0023","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/myc.13148","article-title":"Breakthrough invasive fungal infections: who is at risk?","volume":"63","author":"Jenks","year":"2020","journal-title":"Mycoses"},{"issue":"Suppl 7","key":"10.1016\/j.bjid.2024.103718_bib0024","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/imj.15592","article-title":"Australasian Antifungal Guidelines Steering Committee. Consensus guidelines for the diagnosis and management of invasive fungal disease due to moulds other than Aspergillus in the haematology\/oncology setting, 2021","volume":"51","author":"Bupha-Intr","year":"2021","journal-title":"Intern Med J"},{"key":"10.1016\/j.bjid.2024.103718_bib0025","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/jof2030022","article-title":"Galactomannan and 1,3-\u03b2-d-Glucan testing for the diagnosis of invasive aspergillosis","volume":"2","author":"Lamoth","year":"2016","journal-title":"J Fungi"},{"key":"10.1016\/j.bjid.2024.103718_bib0026","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1016\/j.ijid.2011.01.011","article-title":"Galactomannan- guided preemptive vs. empirical antifungals in the persistently febrile neutropenic patient: a prospective randomized study","volume":"15","author":"Tan","year":"2011","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.bjid.2024.103718_bib0027","article-title":"Pre-emptive antifungal therapy versus empirical antifungal therapy for febrile neutropenia in people with cancer","volume":"11","author":"Uneno","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bjid.2024.103718_bib0028","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1093\/jac\/dkv198","article-title":"Invasive mould sinusitis in patients with haematological malignancies: a 10-year single-centre study","volume":"70","author":"Davoudi","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bjid.2024.103718_bib0029","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1086\/652768","article-title":"Factors associated with mortality in transplant patients with invasive aspergillosis","volume":"50","author":"Baddley","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bjid.2024.103718_bib0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bjid.2024.103718_bib0031","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.2147\/IDR.S405810","article-title":"Epidemiology and factors associated with treatment success of invasive fungal infections among newly hematologic malignancy patients receiving chemotherapy or hematopoietic stem cell transplant in Thailand","volume":"16","author":"Weeraphon","year":"2023","journal-title":"Infect Drug Resist"}],"container-title":["The Brazilian Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867024000011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1413867024000011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:00:07Z","timestamp":1761408007000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1413867024000011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1413867024000011"],"URL":"https:\/\/doi.org\/10.1016\/j.bjid.2024.103718","relation":{},"ISSN":["1413-8670"],"issn-type":[{"type":"print","value":"1413-8670"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Six-year experience with GM test in hematological patients in a public Brazilian tertiary hospital","name":"articletitle","label":"Article Title"},{"value":"The Brazilian Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bjid.2024.103718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedade Brasileira de Infectologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"103718"}}